Pharmaceutical care for advanced small cell lung cancer patient associated with renal insufficiency

LI Meng; LEI Jiachuan; RONG Peipei; YANG Jian; SONG Jinchun

doi:10.3969/j.issn.1006-0111.2016.01.024

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Objective To monitor the medication process of advanced lung cancer patients with renal insufficiency. Methods Pharmaceutical care, pharmaceutical intervention and medication were offered according to the individual condition of patient with renal function based on pharmaceutical experience and related literature. Results The patient finished chemotherapy successfully without adverse reaction. Conclusion Clinical pharmacists should keep improving their knowledge and participating in first-line clinical treatment activities; the patient-centered hospital pharmacy service will be founded and the level of rational medication will be improved when doctors, pharmacists and nurses could cooperate sincerely.

Pharmaceutical care for advanced small cell lung cancer patient associated with renal insufficiency

Department of Pharmacy, Wuhan Unitersity, Renmin Hospital, Wuhan 430060, China

Received Date: 2014-03-20

Rev Recd Date: 2014-10-10

Key words:

Abstract: Objective To monitor the medication process of advanced lung cancer patients with renal insufficiency. Methods Pharmaceutical care, pharmaceutical intervention and medication were offered according to the individual condition of patient with renal function based on pharmaceutical experience and related literature. Results The patient finished chemotherapy successfully without adverse reaction. Conclusion Clinical pharmacists should keep improving their knowledge and participating in first-line clinical treatment activities; the patient-centered hospital pharmacy service will be founded and the level of rational medication will be improved when doctors, pharmacists and nurses could cooperate sincerely.

HTML

Reference (9)

[1]	杨宏云,徐国宾,李海霞. 经体表面积校正后的肌酐清除率与实测值的差异性研究[J]. 中国医刊,2006,41(12):41.
[2]	National Comprehensive Cancer Network. Small Cell Lung Cancer(Version 1.2013). [EB/OL]. http://www.nccn.org/professionals/physician_gls/pdf/sclc.pdf: SCL-C.2012-06-26/2013-08-06.
[3]	中国国家处方集编委会. 中国国家处方集(化学药品与生物制品卷)[M]. 北京:人民军医出版社,2010:15.
[4]	Mathe G, Umezawa H, Umezawa K,et al. Minimal cardiotoxicity of THP-Adriamycin (Pirarubicin)in hamsters and in cancer patients,its greater cardiac tolerance compared to other antharacyclines [C]. Landsberg/Lech: Ecomed, 1988: 35-46.
[5]	Lichtman SM, Wildiers H, Launay-Vacher V,et al. International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosingin elderly cancer patients with renal insufficiency[J]. Eur J Cancer, 2007, 43(1): 24.
[6]	邹燕梅,于世英. NCCN止吐临床指引[J]. 循证医学,2006,6(1):57-60.
[7]	国家药典委员会. 中华人民共和国药典临床用药须知(化学药和生物制品卷)[M]. 北京:人民卫生出版社,2005:720.
[8]	黎杰,林宇宁,黎仲然,等. 门静脉注药化疗对胃酸分泌的影响[J].世界华人消化杂志,2000,8(特刊8):84.
[9]	朴瑛,刘兆喆,丁震宇,等. 抗幽门螺杆菌治疗在肿瘤化疗止吐中的作用研究[J].中国肿瘤临床杂志,2012,39(22):1832.

Message Board

Pharmaceutical care for advanced small cell lung cancer patient associated with renal insufficiency

doi: 10.3969/j.issn.1006-0111.2016.01.024

Abstract

References

Proportional views

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Related

Proportional views